Non-adherence to antiretroviral therapy in Yaounde: Prevalence, determinants and the concordance of two screening criteria

Journal of Infection and Public Health

Volumn 6, Issue 4, 2013, Pages 307-315

  Pefura Yone, Eric Walter ^a,b   Soh, Emmanuel ^b   Kengne, André Pascal ^c   Balkissou, Adamou Dodo ^a   Kuaban, Christopher ^a,b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Yaounde Jamot Hospital   (Cameroon)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Adherence; Antiretroviral therapy; Cameroon; HIV infection

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE;

ADULT; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT TOOL; CONDOM; CROSS-SECTIONAL STUDY; EMPLOYMENT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PRIVACY; PROPHYLAXIS; RELIGION; SELF REPORT; TREATMENT DURATION; TUBERCULOSIS;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMEROON; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84879603656     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2013.02.003     Document Type: Article

References (34)

1. WHO, Global Health Observatory (GHO). HIV/AIDS, [accessed 6.02.13]. http://www.who.int/gho/hiv/en/index.html.
2. WHO, The world health report - Health systems financing: the path to universal coverage. [accessed 12.04.12]. http://www.who.int/whr/2010/en/index.html.
3. Samb B., Evans T., Dybul M., Atun R., Moatti J.P., Nishtar S., et al. An assessment of interactions between global health initiatives and country health systems. Lancet 2009, 373:2137-2169.
4. Boyer S., Clerc I., Bonono C.R., Marcellin F., Bile P.C., Ventelou B. Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: individual and healthcare supply-related factors. Social Science and Medicine 2011, 72:1383-1392.
5. Lima V.D., Harrigan R., Murray M., Moore D.M., Wood E., Hogg R.S., et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS 2008, 22:2371-2380.
6. Mills E.J., Nachega J.B., Buchan I., Orbinski J., Attaran A., Singh S., et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006, 296:679-690.
7. Nguyen V.K., Grennan T., Peschard K., Tan D., Tiendrebeogo I. Antiretroviral use in Ouagadougou, Burkina Faso. AIDS 2003, 17(Suppl.(3)):S109-S111.
8. Ollivier F., N'Kam M., Midoungue C., Rey J.L. Study conducted at the Yaounde University Hospital on anti-retroviral treatment compliance (Cameroon). Sante Publique 2005, 17:559-568.
9. Diabate S., Alary M., Koffi C.K. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire. AIDS 2007, 21:1799-1803.
10. Simoni J.M., Kurth A.E., Pearson C.R., Pantalone D.W., Merrill J.O., Frick P.A. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior 2006, 10:227-245.
11. National AIDS Control Committe, Towards universal access to care and treatment for adults and children living with HIV/AIDS in Cameroon. Progress Report n 4. Yaoundé, Cameroon: Ministry of Public Health, Republic of Cameroon; 2006.
12. Pefura Yone E.W., Betyoumin A.F., Kengne A.P., Kaze Folefack F.J., Ngogang J. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study. AIDS Research and Therapy 2011, 8:33.
13. Pefura Yone E.W., Kengne A.P., Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study. BMJ Open 2011, 1:e000289.
14. Ministère de la Santé Publique du Cameroun. Directives nationales de prise en charge par les antirétroviraux des personnes (Adultes et Adolescents) infectés par le VIH. MINSANTE, République du Cameroun; 2010.
15. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine 2006, 166:1092-1097.
16. Spitzer R.L., Kroenke K., Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282:1737-1744.
17. Mannheimer S., Friedland G., Matts J., Child C., Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases 2002, 34:1115-1121.
18. Mannheimer S.B., Mukherjee R., Hirschhorn L.R., Dougherty J., Celano S.A., Ciccarone D., et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care 2006, 18:853-861.
19. Mannheimer S.B., Matts J., Telzak E., Chesney M., Child C., Wu A.W., et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005, 17:10-22.
20. Ortego C., Huedo-Medina T.B., Llorca J., Sevilla L., Santos P., Rodriguez E., et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS and behavior 2011, 15:1381-1396.
21. Amberbir A., Woldemichael K., Getachew S., Girma B., Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 2008, 8:265.
22. Wakibi S.N., Ng'ang'a Z.W., Mbugua G.G. Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Research and Therapy 2011, 8:43.
23. Oyugi J.H., Byakika-Tusiime J., Charlebois E.D., Kityo C., Mugerwa R., Mugyenyi P., et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes 2004, 36:1100-1102.
24. Gao X., Nau D.P. Congruence of three self-report measures of medication adherence among HIV patients. The Annals of pharmacotherapy 2000, 34:1117-1122.
25. Berg K.M., Arnsten J.H. Practical and conceptual challenges in measuring antiretroviral adherence. Journal of Acquired Immune Deficiency Syndromes 2006, 43(Suppl. (1)):S79-S87.
26. Hardon A, Davey S, Gerritis T, Hodgkin C, Irunde H, Kgatlwane J, et al. From access to adherence: the challenges of antiretroviral treatment: studies from Botswana, Tanzania and Uganda. Available from: URL: [accessed 14.09.12]. http://www.who.int/medicinedocs/pdf/s13400e/s13400e.pdf.
27. Nakimuli-Mpungu E., Bass J.K., Alexandre P., Mills E.J., Musisi S., Ram M., et al. Depression alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS and Behavior 2011.
28. Mayrargue C. Les dynamiques paradoxales du pentecÔtisme en Afrique subsaharienne. Available from: URL: [accessed 12.04.12]. http://www.ifri.org/downloads/mayrarguefinalfr.pdf.
29. Talam N.C., Gatongi P., Rotich J., Kimaiyo S. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. East African Journal of Public Health 2008, 5:74-78.
30. Campos L.N., Guimaraes M.D., Remien R.H. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS and Behavior 2010, 14:289-299.
31. Andrade S.E., Kahler K.H., Frech F., Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety 2006, 15:565-574.
32. Goldstein M.K., Coleman R.W., Tu S.W., Shankar R.D., O'Connor M.J., Musen M.A., et al. Translating research into practice: organizational issues in implementing automated decision support for hypertension in three medical centers. Journal of the American Medical Informatics Association 2004, 11:368-376.
33. Mabotuwana T., Warren J., Orr M., Kenealy T., Harrison J. Using primary care prescribing data to improve GP awareness of antidepressant adherence issues. Informatics for Primary Care 2011, 19:7-15.
34. Barnighausen T., Chaiyachati K., Chimbindi N., Peoples A., Haberer J., Newell M.L. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. The Lancet infectious diseases 2011, 11:942-951.